Lipefilgrastim (Lonquex)

From HemOnc.org - A Hematology Oncology Wiki
(Redirected from Lipefilgrastim (XM22))
Jump to navigation Jump to search

Mechanism of action

From NCI: "A long acting glyco-pegylated recombinant form of human granulocyte colony-stimulating factor (G-CSF), with hematopoietic activity. Similar to G-CSF, lipegfilgrastim binds to and activates specific cell surface receptors, and stimulates neutrophil progenitor proliferation and differentiation."

History of changes in EMA indication

  • 2013-07-25: Initial authorization

Also known as

  • Code name: XM22
  • Brand name: Lonquex